1999Chinese Journal of New Drugs and Clinical RemediesRequires access

Etofesalamide ointment in treatment of chronic eczema: A randomized controlled trial

John P. New, Changhai Ding

Open publisher page 0 citations

Abstract

AIM: To evaluate the efficacy and safety of etofesalamide ointmant in the treatment of chronic eczema. METHODS: A randomized, single_blind and controlled clinical trial of etofesalamide ointment vs its ointment base was performed. Thirty patients (M 23, F 7; age 50 a±s 15 a) with chronic eczema were treated with etofesalamide ointment (given thinly on the surface 3 times daily) for 4 wk; Another 30 patients (M 24, F 6; age 44 a±14 a) were treated with ointment base (given thinly on the surface 3 times daily) for 4 wk. RESULTS: The efficacy rates of etofesalamide ointment and the base on 2 wk and 4 wk were 20%, 63%, and 10%, 14%, respectively. The adverse reaction rates of etofesalamide ointment and the ointment base were 7% and 3%, respectively. CONCLUSION: Etofesalamide ointment is effective in the treatment of chronic eczema with mild adverse reactions.

About this research paper

What this paper is about

AIM: To evaluate the efficacy and safety of etofesalamide ointmant in the treatment of chronic eczema. METHODS: A randomized, single_blind and controlled clinical trial of etofesalamide ointment vs its ointment base was performed. Thirty patients (M 23, F 7; age 50 a±s 15 a) with chronic eczema were treated with etofesalamide ointment (given thinly on the surface 3 times daily) for 4 wk; Another 30 patients (M 24, F 6; age 44 a±14 a) were treated with ointment base (given thinly on the surface 3 times daily) for 4 wk. RESULTS: The efficacy rates of etofesalamide ointment and the base on 2 wk and 4 wk were 20%, 63%, and 10%, 14%, respectively. The adverse reaction rates of etofesalamide ointment and the ointment base were 7% and 3%, respectively. CONCLUSION: Etofesalamide ointment is effective in the treatment of chronic eczema with mild adverse reactions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To evaluate the efficacy and safety of etofesalamide ointmant in the treatment of chronic eczema. METHODS: A randomized, single_blind and controlled clinical trial of etofesalamide ointment vs its ointment base was performed. Thirty patients (M 23, F 7; age 50 a±s 15 a) with chronic eczema were treated with etofesalamide ointment (given thinly on the surface 3 times daily) for 4 wk; Another 30 patients (M 24, F 6; age 44 a±14 a) were treated with ointment base (given thinly on the surface 3 times daily) for 4 wk. RESULTS: The efficacy rates of etofesalamide ointment and the base on 2 wk and 4 wk were 20%, 63%, and 10%, 14%, respectively. The adverse reaction rates of etofesalamide ointment and the ointment base were 7% and 3%, respectively. CONCLUSION: Etofesalamide ointment is effective in the treatment of chronic eczema with mild adverse reactions.

Key concepts: Medicine, Randomized controlled trial, Adverse effect, Clinical trial, Dermatology, Surgery, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Etofesalamide ointment in treatment of chronic eczema: A randomized controlled trial — Research Paper | ScholarLens